Bugao, Nida Z.
HRN: 00-10-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
MUPIROCIN 2%, 15G (TUBE)
04/02/2024
04/09/2024
TOPICAL
15g
7 Days
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes